CN Stock MarketDetailed Quotes

002603 Shijiazhuang Yiling Pharmaceutical

Watchlist
  • 18.02
  • +1.42+8.55%
Market Closed Sep 30 15:00 CST
30.11BMarket Cap108.55P/E (TTM)

Shijiazhuang Yiling Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-32.19%4.6B
-35.89%2.52B
-17.67%10.32B
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
Operating revenue
-32.19%4.6B
-35.89%2.52B
-17.67%10.32B
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
Other operating revenue
14.27%3.25M
----
-73.27%3.48M
----
-64.36%2.85M
----
113.13%13.04M
----
156.01%7.99M
----
Total operating cost
-18.86%3.98B
-13.10%2.16B
-9.80%8.72B
5.70%6.58B
14.62%4.9B
16.31%2.49B
12.93%9.67B
-7.39%6.22B
-10.74%4.28B
-24.98%2.14B
Operating cost
-17.36%2.15B
-11.21%1.22B
-2.92%4.41B
10.82%3.34B
23.65%2.6B
29.96%1.38B
23.35%4.54B
3.89%3.02B
1.03%2.1B
-19.08%1.06B
Operating tax surcharges
-8.56%71.96M
-3.89%44.32M
-33.58%135.13M
-11.46%110.22M
-7.89%78.69M
-4.21%46.12M
46.99%203.45M
16.40%124.49M
9.96%85.43M
-10.24%48.14M
Operating expense
-29.30%1.08B
-22.41%567.76M
-17.00%2.7B
-3.74%2.09B
3.06%1.52B
-2.10%731.73M
-5.10%3.26B
-22.34%2.17B
-27.71%1.48B
-36.84%747.42M
Administration expense
-7.97%271.38M
-17.51%138.16M
-3.30%592.04M
21.97%430.36M
28.06%294.89M
39.37%167.48M
23.23%612.22M
1.65%352.84M
4.50%230.27M
4.64%120.17M
Financial expense
262.67%17.17M
1,603.45%8.44M
32.37%26.37M
80.26%9.45M
-41.13%4.73M
-91.07%495.21K
15.02%19.92M
-80.78%5.24M
-13.90%8.04M
116.41%5.55M
-Interest expense (Financial expense)
26.85%20.04M
58.06%9.55M
15.11%38.9M
12.91%25.87M
-0.55%15.8M
-26.68%6.04M
-0.53%33.8M
-43.71%22.91M
-16.53%15.89M
35.73%8.24M
-Interest Income (Financial expense)
65.30%-4.07M
74.67%-2.08M
-24.80%-16.09M
7.74%-17.16M
-17.67%-11.73M
-127.02%-8.2M
36.93%-12.9M
-13.80%-18.6M
16.01%-9.97M
20.83%-3.61M
Research and development
-2.31%393.29M
9.55%180.59M
-17.33%853.19M
7.62%593.71M
7.64%402.61M
4.29%164.84M
30.28%1.03B
2.62%551.68M
4.03%374.04M
-15.73%158.06M
Credit Impairment Loss
-145.02%-6.71M
-315.75%-3.38M
-40.01%-23.7M
-156.05%-10.49M
-37.89%-2.74M
605.36%1.57M
55.11%-16.93M
19.44%-4.1M
11.84%-1.99M
-141.80%-309.8K
Asset Impairment Loss
80.41%-3.12M
89.28%-1.56M
67.39%-35.36M
-528.23%-15.92M
-151.78%-15.92M
---14.54M
-278.74%-108.43M
---2.53M
---6.32M
----
Other net revenue
-12.35%45.34M
185.19%32.09M
596.40%180.71M
310.88%130.8M
274.68%51.73M
559.33%11.25M
-403.68%-36.4M
-44.63%31.83M
-69.44%13.81M
-82.61%1.71M
Fair value change income
-6.48%25.91M
22.69%12.95M
110.07%39.35M
3,200.46%44.43M
2,586.99%27.7M
2,279.16%10.56M
910.90%18.73M
0.00%1.35M
15.04%1.03M
-80.78%443.75K
Invest income
-63.81%927.29K
187.12%3.81M
458.97%25.95M
94.38%-389.59K
149.87%2.56M
-13.01%-4.38M
69.56%-7.23M
-371.14%-6.93M
-377.43%-5.14M
-1,203.62%-3.87M
-Including: Investment income associates
36.95%-6.21K
---2.9K
-404.37%-15.06K
---10.01K
---9.85K
----
---2.99K
----
----
----
Asset deal income
-3.21%-982.25K
54.61%-58.22K
73.67%-819.3K
49.88%-1.49M
63.18%-951.69K
71.35%-128.28K
-23.64%-3.11M
-284.25%-2.96M
-267.27%-2.58M
66.27%-447.7K
Other revenue
-28.62%29.32M
11.81%20.32M
117.58%175.28M
143.85%114.65M
42.60%41.07M
208.31%18.17M
-21.58%80.56M
-20.91%47.01M
-36.53%28.8M
-23.87%5.89M
Operating profit
-65.39%670.96M
-73.13%391.39M
-37.10%1.78B
21.25%2.13B
48.93%1.94B
149.70%1.46B
80.33%2.83B
21.02%1.76B
13.39%1.3B
-29.29%583.45M
Add:Non operating Income
-56.54%1.2M
-47.76%826.48K
0.86%8.44M
-10.37%3.86M
102.52%2.76M
113.72%1.58M
-23.37%8.37M
-50.36%4.31M
-69.39%1.36M
-56.65%740.25K
Less:Non operating expense
273.18%28.84M
949.44%23.77M
81.66%104.06M
-51.71%26.48M
-77.36%7.73M
-84.80%2.26M
118.02%57.28M
314.46%54.85M
210.17%34.13M
502.24%14.9M
Total profit
-66.73%643.32M
-74.70%368.46M
-39.43%1.68B
23.52%2.11B
52.38%1.93B
155.79%1.46B
78.97%2.78B
17.91%1.71B
11.17%1.27B
-30.95%569.3M
Less:Income tax cost
-64.67%116.7M
-73.88%66.54M
-19.62%339.91M
20.19%352.15M
49.14%330.34M
196.95%254.75M
99.39%422.87M
31.20%292.99M
25.13%221.5M
-42.57%85.79M
Net profit
-67.15%526.63M
-74.87%301.92M
-42.98%1.34B
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.74%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
Net profit from continuing operation
-67.15%526.63M
-74.87%301.92M
-42.98%1.34B
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.74%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
Less:Minority Profit
-28.95%-3.83M
-86.37%-2.01M
-62.08%-8.08M
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
Net profit of parent company owners
-66.97%530.46M
-74.73%303.93M
-42.76%1.35B
24.35%1.76B
53.16%1.61B
148.29%1.2B
75.82%2.36B
15.58%1.41B
8.76%1.05B
-28.22%484.32M
Earning per share
Basic earning per share
-66.97%0.3175
-74.73%0.1819
-42.76%0.8095
24.36%1.0527
53.17%0.9613
148.21%0.7198
75.81%1.4142
15.58%0.8465
8.75%0.6276
-28.18%0.29
Diluted earning per share
-66.97%0.3175
-74.73%0.1819
-42.76%0.8095
24.36%1.0527
53.17%0.9613
148.21%0.7198
75.81%1.4142
15.58%0.8465
8.75%0.6276
-28.18%0.29
Other composite income
-97.93%20.58K
-109.64%-33.17K
-75.74%604.59K
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
Other composite income of parent company owners
-97.93%20.58K
-109.64%-33.17K
-75.74%604.59K
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
Total composite income
-67.17%526.65M
-74.88%301.89M
-43.02%1.34B
24.07%1.75B
53.01%1.6B
148.64%1.2B
76.01%2.36B
15.65%1.41B
8.74%1.05B
-28.42%483.34M
Total composite income of parent company owners
-66.99%530.48M
-74.74%303.89M
-42.80%1.35B
24.21%1.76B
53.10%1.61B
148.45%1.2B
76.09%2.37B
15.75%1.42B
8.89%1.05B
-28.27%484.15M
Total composite income of minority owners
-28.95%-3.83M
-86.37%-2.01M
-62.08%-8.08M
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -32.19%4.6B-35.89%2.52B-17.67%10.32B7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B
Operating revenue -32.19%4.6B-35.89%2.52B-17.67%10.32B7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B
Other operating revenue 14.27%3.25M-----73.27%3.48M-----64.36%2.85M----113.13%13.04M----156.01%7.99M----
Total operating cost -18.86%3.98B-13.10%2.16B-9.80%8.72B5.70%6.58B14.62%4.9B16.31%2.49B12.93%9.67B-7.39%6.22B-10.74%4.28B-24.98%2.14B
Operating cost -17.36%2.15B-11.21%1.22B-2.92%4.41B10.82%3.34B23.65%2.6B29.96%1.38B23.35%4.54B3.89%3.02B1.03%2.1B-19.08%1.06B
Operating tax surcharges -8.56%71.96M-3.89%44.32M-33.58%135.13M-11.46%110.22M-7.89%78.69M-4.21%46.12M46.99%203.45M16.40%124.49M9.96%85.43M-10.24%48.14M
Operating expense -29.30%1.08B-22.41%567.76M-17.00%2.7B-3.74%2.09B3.06%1.52B-2.10%731.73M-5.10%3.26B-22.34%2.17B-27.71%1.48B-36.84%747.42M
Administration expense -7.97%271.38M-17.51%138.16M-3.30%592.04M21.97%430.36M28.06%294.89M39.37%167.48M23.23%612.22M1.65%352.84M4.50%230.27M4.64%120.17M
Financial expense 262.67%17.17M1,603.45%8.44M32.37%26.37M80.26%9.45M-41.13%4.73M-91.07%495.21K15.02%19.92M-80.78%5.24M-13.90%8.04M116.41%5.55M
-Interest expense (Financial expense) 26.85%20.04M58.06%9.55M15.11%38.9M12.91%25.87M-0.55%15.8M-26.68%6.04M-0.53%33.8M-43.71%22.91M-16.53%15.89M35.73%8.24M
-Interest Income (Financial expense) 65.30%-4.07M74.67%-2.08M-24.80%-16.09M7.74%-17.16M-17.67%-11.73M-127.02%-8.2M36.93%-12.9M-13.80%-18.6M16.01%-9.97M20.83%-3.61M
Research and development -2.31%393.29M9.55%180.59M-17.33%853.19M7.62%593.71M7.64%402.61M4.29%164.84M30.28%1.03B2.62%551.68M4.03%374.04M-15.73%158.06M
Credit Impairment Loss -145.02%-6.71M-315.75%-3.38M-40.01%-23.7M-156.05%-10.49M-37.89%-2.74M605.36%1.57M55.11%-16.93M19.44%-4.1M11.84%-1.99M-141.80%-309.8K
Asset Impairment Loss 80.41%-3.12M89.28%-1.56M67.39%-35.36M-528.23%-15.92M-151.78%-15.92M---14.54M-278.74%-108.43M---2.53M---6.32M----
Other net revenue -12.35%45.34M185.19%32.09M596.40%180.71M310.88%130.8M274.68%51.73M559.33%11.25M-403.68%-36.4M-44.63%31.83M-69.44%13.81M-82.61%1.71M
Fair value change income -6.48%25.91M22.69%12.95M110.07%39.35M3,200.46%44.43M2,586.99%27.7M2,279.16%10.56M910.90%18.73M0.00%1.35M15.04%1.03M-80.78%443.75K
Invest income -63.81%927.29K187.12%3.81M458.97%25.95M94.38%-389.59K149.87%2.56M-13.01%-4.38M69.56%-7.23M-371.14%-6.93M-377.43%-5.14M-1,203.62%-3.87M
-Including: Investment income associates 36.95%-6.21K---2.9K-404.37%-15.06K---10.01K---9.85K-------2.99K------------
Asset deal income -3.21%-982.25K54.61%-58.22K73.67%-819.3K49.88%-1.49M63.18%-951.69K71.35%-128.28K-23.64%-3.11M-284.25%-2.96M-267.27%-2.58M66.27%-447.7K
Other revenue -28.62%29.32M11.81%20.32M117.58%175.28M143.85%114.65M42.60%41.07M208.31%18.17M-21.58%80.56M-20.91%47.01M-36.53%28.8M-23.87%5.89M
Operating profit -65.39%670.96M-73.13%391.39M-37.10%1.78B21.25%2.13B48.93%1.94B149.70%1.46B80.33%2.83B21.02%1.76B13.39%1.3B-29.29%583.45M
Add:Non operating Income -56.54%1.2M-47.76%826.48K0.86%8.44M-10.37%3.86M102.52%2.76M113.72%1.58M-23.37%8.37M-50.36%4.31M-69.39%1.36M-56.65%740.25K
Less:Non operating expense 273.18%28.84M949.44%23.77M81.66%104.06M-51.71%26.48M-77.36%7.73M-84.80%2.26M118.02%57.28M314.46%54.85M210.17%34.13M502.24%14.9M
Total profit -66.73%643.32M-74.70%368.46M-39.43%1.68B23.52%2.11B52.38%1.93B155.79%1.46B78.97%2.78B17.91%1.71B11.17%1.27B-30.95%569.3M
Less:Income tax cost -64.67%116.7M-73.88%66.54M-19.62%339.91M20.19%352.15M49.14%330.34M196.95%254.75M99.39%422.87M31.20%292.99M25.13%221.5M-42.57%85.79M
Net profit -67.15%526.63M-74.87%301.92M-42.98%1.34B24.21%1.75B53.07%1.6B148.48%1.2B75.74%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M
Net profit from continuing operation -67.15%526.63M-74.87%301.92M-42.98%1.34B24.21%1.75B53.07%1.6B148.48%1.2B75.74%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M
Less:Minority Profit -28.95%-3.83M-86.37%-2.01M-62.08%-8.08M-115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K
Net profit of parent company owners -66.97%530.46M-74.73%303.93M-42.76%1.35B24.35%1.76B53.16%1.61B148.29%1.2B75.82%2.36B15.58%1.41B8.76%1.05B-28.22%484.32M
Earning per share
Basic earning per share -66.97%0.3175-74.73%0.1819-42.76%0.809524.36%1.052753.17%0.9613148.21%0.719875.81%1.414215.58%0.84658.75%0.6276-28.18%0.29
Diluted earning per share -66.97%0.3175-74.73%0.1819-42.76%0.809524.36%1.052753.17%0.9613148.21%0.719875.81%1.414215.58%0.84658.75%0.6276-28.18%0.29
Other composite income -97.93%20.58K-109.64%-33.17K-75.74%604.59K-60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K
Other composite income of parent company owners -97.93%20.58K-109.64%-33.17K-75.74%604.59K-60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K
Total composite income -67.17%526.65M-74.88%301.89M-43.02%1.34B24.07%1.75B53.01%1.6B148.64%1.2B76.01%2.36B15.65%1.41B8.74%1.05B-28.42%483.34M
Total composite income of parent company owners -66.99%530.48M-74.74%303.89M-42.80%1.35B24.21%1.76B53.10%1.61B148.45%1.2B76.09%2.37B15.75%1.42B8.89%1.05B-28.27%484.15M
Total composite income of minority owners -28.95%-3.83M-86.37%-2.01M-62.08%-8.08M-115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data